Triptolide is a diterpene triepoxide, immunosuppresive agent extracted from the Chinese herb Tripterygium wilfordii. It has immunosuppressive, anti-inflammatory, antiproliferative and antitumour effects. Triptolide is an NF-κB activation inhibitor.
Structure of 38748-32-2
* For research and manufacturing use only. We do not sell to patients.
Size | Price | Stock | Quantity |
---|---|---|---|
20 mg | $285 | In stock |
Looking for different specifications? Click to request a custom quote!
Capabilities & Facilities
NCT Number | Condition Or Disease | Phase | Start Date | Sponsor | Status |
---|---|---|---|---|---|
NCT00801268 | Polycystic Kidney | Not Applicable | 2015-03-30 | Zhi-Hong Liu, M.D. | Terminated (high rate of drop-out) |
NCT02115659 | Autosomal Dominant Polycystic Kidney Disease (ADPKD) | Phase 3 | 2014-04-17 | Shanghai Changzheng Hospital | Unknown Verified April 2014 by Mei changlin, Shanghai Changzheng Hospital. Recruitment status was Recruiting |
NCT02219672 | AIDS/HIV PROBLEM | Phase 3 | 2014-08-19 | Peking Union Medical College | Unknown Verified August 2014 by LI Taisheng, Peking Union Medical College. Recruitment status was Recruiting |
NCT04896073 | Adenosquamous Carcinoma of the Pancreas | Phase 2 | 2021-11-29 | National Cancer Institute (NCI) | Recruiting |
NCT01817283 | HIV | Phase 1, Phase 2 | 2013-03-25 | LI Taisheng | Unknown Verified March 2013 by LI Taisheng, Peking Union Medical College. Recruitment status was Recruiting |
Contact our experts today for pricing and comprehensive details on our ADC offerings.
From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.
Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.
Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.